The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwNHL 2019 | Genetic basis of immune evasion in lymphoid malignancies: more heterogenetity than we think?
John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, and Margaret Shipp, MD, Dana-Farber Cancer Institute, Boston, MA, discuss the current classifications of lymphoma, and the genetics underlying the prognostic features of non-Hodgkin lymphoma at the 17th International Workshop on Non-Hodgkin Lymphoma held in Boston, MA. The speakers also discuss the issues of heterogeneity in diffuse large B-cell lymphoma.
